Flexible Micro Spring Array Device for High-Throughput Enrichment of Viable Circulating Tumor Cells
- 1 February 2014
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 60 (2), 323-333
- https://doi.org/10.1373/clinchem.2013.206805
Abstract
BACKGROUND: The dissemination of circulating tumor cells (CTCs) that cause metastases in distant organs accounts for the majority of cancer-related deaths. CTCs have been established as a cancer biomarker of known prognostic value. The enrichment of viable CTCs for ex vivo analysis could further improve cancer diagnosis and guide treatment selection. We designed a new flexible micro spring array (FMSA) device for the enrichment of viable CTCs independent of antigen expression. METHODS: Unlike previous microfiltration devices, flexible structures at the micro scale minimize cell damage to preserve viability, while maximizing throughput to allow rapid enrichment directly from whole blood with no need for sample preprocessing. Device performance with respect to capture efficiency, enrichment against leukocytes, viability, and proliferability was characterized. CTCs and CTC microclusters were enriched from clinical samples obtained from breast, lung, and colorectal cancer patients. RESULTS: The FMSA device enriched tumor cells with 90% capture efficiency, higher than 104 enrichment, and better than 80% viability from 7.5-mL whole blood samples in 2 device. The FMSA detected at least 1 CTC in 16 out of 21 clinical samples (approximately 76%) compared to 4 out of 18 (approximately 22%) detected with the commercial CellSearch® system. There was no incidence of clogging in over 100 tested fresh whole blood samples. CONCLUSIONS: The FMSA device provides a versatile platform capable of viable enrichment and analysis of CTCs from clinically relevant volumes of whole blood.Keywords
Funding Information
- Penn State Hershey Cancer Institute
- National Cancer Institute
- National Institutes of Health (R21CA161835, DP2CA174508)
This publication has 39 references indexed in Scilit:
- Circulating Tumor Cells: Liquid Biopsy of CancerClinical Chemistry, 2013
- Microtube Device for Selectin-Mediated Capture of Viable Circulating Tumor Cells from BloodClinical Chemistry, 2012
- Functional Characterization of Circulating Tumor Cells with a Prostate-Cancer-Specific Microfluidic DevicePLOS ONE, 2012
- Highly Efficient Capture of Circulating Tumor Cells by Using Nanostructured Silicon Substrates with Integrated Chaotic MicromixersAngewandte Chemie-International Edition, 2011
- Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper deviceProceedings of the National Academy of Sciences, 2009
- Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patientsBreast Cancer Research, 2008
- Isolation of rare circulating tumour cells in cancer patients by microchip technologyNature, 2007
- Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate CancerClinical Cancer Research, 2007
- Metastasis: a question of life or deathNature Reviews Cancer, 2006
- Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast CancerNew England Journal of Medicine, 2004